Amrize stock: Barclays sets USD 40.00 target for Amrize stock

Published on 10/22/2026 at 15:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 revenue rose 8.39 percent to USD 3.49 billion. Amrize stock costs EUR 34.34 on October 22, 2026.

Analyst target and reporting date

Barclays set a USD 40.00 target and kept a Hold rating on October 16, 2026.
Second-quarter revenue rose 8.39 percent to USD 3.49 billion from USD 3.22 billion.
Amrize stock costs EUR 34.34 at Lang & Schwarz on October 22, 2026 at 3:08 p.m. CEST.
Amrize is scheduled to publish third-quarter results on October 29, 2026.

Amrize, CH1430134226, Illustration mit AI erstellt.

Barclays set a USD 40.00 price target for Amrize and maintained a Hold rating on October 16, 2026. According to Markets Insider, analyst Adam Seiden issued the target as the company approached its third-quarter results. Amrize was trading at EUR 34.34 at Lang & Schwarz on October 22, 2026 at 3:08 p.m. CEST.

Revenue growth meets target pressure

Amrize reported USD 3.49 billion in second-quarter revenue for the period ended June 30, 2026, compared with USD 3.22 billion a year earlier. That represents growth of 8.39 percent. Net profit reached USD 478 million, up from USD 429 million in the prior-year quarter, according to Markets Insider.

Stock stays below its yearly high

Amrize was last quoted at USD 38.80 on the NYSE on October 21, 2026 at 4:00 p.m. ET. Its 52-week range was USD 35.78 to USD 65.94 on that date, placing the latest US quote USD 27.14 below the high. The company had a market capitalization of USD 21.2 billion and volume of 2,855,093 shares in the same quote.

Analysts disagree on the next step

Barclays target of USD 40.00 stands 3.09 percent above the USD 38.80 US quote dated October 21, 2026. By contrast, RBC Capital lowered its target from USD 48.00 to USD 32.00 and retained an Underperform rating on October 9, 2026, citing input-cost inflation and execution risks, as Investing.com reported.

October 29 results set the next date

Amrize is scheduled to publish its third-quarter 2026 financial results on October 29, 2026. The date appears on the company investor-relations page, which lists the event as a Q3 2026 10-Q publication and earnings conference call. That release should provide the next quantified test of revenue, profit and cost control.

EUR 34.34 at Lang & Schwarz

The euro quotation gives German investors a current view of Amrize while the NYSE listing supplies the companys main market reference. The US price range shows that the stock remains materially below its yearly high, while the analyst targets point in different directions.

The further course of trading is shown by the continuously updated real-time quote of Amrize stock.